131 related articles for article (PubMed ID: 28388523)
1. Structure-activity relationship studies of 1,7-diheteroarylhepta-1,4,6-trien-3-ones with two different terminal rings in prostate epithelial cell models.
Wang R; Zhang X; Chen C; Chen G; Sarabia C; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Jun; 133():208-226. PubMed ID: 28388523
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of 1,7-diheteroarylhepta-1,4,6-trien-3-ones as curcumin-based anticancer agents.
Wang R; Zhang X; Chen C; Chen G; Zhong Q; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Mar; 110():164-80. PubMed ID: 26827161
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of 1,9-diheteroarylnona-1,3,6,8-tetraen-5-ones as a new class of anti-prostate cancer agents.
Zhang X; Wang R; Perez GR; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2016 Oct; 24(19):4692-4700. PubMed ID: 27543391
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric 1,5-diarylpenta-1,4-dien-3-ones: Antiproliferative activity in prostate epithelial cell models and pharmacokinetic studies.
Zhang X; Guo S; Chen C; Perez GR; Zhang C; Patanapongpibul M; Subrahmanyam N; Wang R; Keith J; Chen G; Dong Y; Zhang Q; Zhong Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2017 Sep; 137():263-279. PubMed ID: 28601720
[TBL] [Abstract][Full Text] [Related]
5. Structure-Activity Relationship and Pharmacokinetic Studies of 1,5-Diheteroarylpenta-1,4-dien-3-ones: A Class of Promising Curcumin-Based Anticancer Agents.
Wang R; Chen C; Zhang X; Zhang C; Zhong Q; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
J Med Chem; 2015 Jun; 58(11):4713-26. PubMed ID: 25961334
[TBL] [Abstract][Full Text] [Related]
6. Optimization of diarylpentadienones as chemotherapeutics for prostate cancer.
Patanapongpibul M; Zhang C; Chen G; Guo S; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2018 Sep; 26(16):4751-4760. PubMed ID: 30121214
[TBL] [Abstract][Full Text] [Related]
7. Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.
Vue B; Zhang S; Zhang X; Parisis K; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2016 Feb; 109():36-46. PubMed ID: 26748997
[TBL] [Abstract][Full Text] [Related]
8. 3-O-Substituted-3',4',5'-trimethoxyflavonols: Synthesis and cell-based evaluation as anti-prostate cancer agents.
Li X; Lee M; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem; 2017 Sep; 25(17):4768-4777. PubMed ID: 28760528
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship and pharmacokinetic studies of 3-O-substitutedflavonols as anti-prostate cancer agents.
Li X; Zhang C; Guo S; Rajaram P; Lee M; Chen G; Fong R; Gonzalez A; Zhang Q; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2018 Sep; 157():978-993. PubMed ID: 30165345
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents.
Samaan N; Zhong Q; Fernandez J; Chen G; Hussain AM; Zheng S; Wang G; Chen QH
Eur J Med Chem; 2014 Mar; 75():123-31. PubMed ID: 24531225
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, cytotoxicity against human oral cancer KB cells and structure-activity relationship studies of trienone analogues of curcuminoids.
Chuprajob T; Changtam C; Chokchaisiri R; Chunglok W; Sornkaew N; Suksamrarn A
Bioorg Med Chem Lett; 2014 Jul; 24(13):2839-44. PubMed ID: 24857542
[TBL] [Abstract][Full Text] [Related]
12. 3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.
Zhang S; Vue B; Huang M; Zhang X; Lee T; Chen G; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Jul; 26(14):3226-3231. PubMed ID: 27261177
[TBL] [Abstract][Full Text] [Related]
13. Stereoselective synthesis of the four 16-hydroxymethyl-3-methoxy- and 16-hydroxymethyl-3-benzyloxy-13α-estra-1,3,5(10)-trien-17-ol isomers and their antiproliferative activities.
Kiss A; Mernyák E; Wölfling J; Sinka I; Zupkó I; Schneider G
Steroids; 2018 Jun; 134():67-77. PubMed ID: 29501755
[TBL] [Abstract][Full Text] [Related]
14. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of new steroidal pyridines as potential anti-prostate cancer agents.
Shi YK; Wang B; Shi XL; Zhao YD; Yu B; Liu HM
Eur J Med Chem; 2018 Feb; 145():11-22. PubMed ID: 29310026
[TBL] [Abstract][Full Text] [Related]
16. 12,13-Aziridinyl Epothilones. Stereoselective Synthesis of Trisubstituted Olefinic Bonds from Methyl Ketones and Heteroaromatic Phosphonates and Design, Synthesis, and Biological Evaluation of Potent Antitumor Agents.
Nicolaou KC; Rhoades D; Wang Y; Bai R; Hamel E; Aujay M; Sandoval J; Gavrilyuk J
J Am Chem Soc; 2017 May; 139(21):7318-7334. PubMed ID: 28513142
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiproliferative activity of 2-aryl-4-oxo-thiazolidin-3-yl-amides for prostate cancer.
Gududuru V; Hurh E; Dalton JT; Miller DD
Bioorg Med Chem Lett; 2004 Nov; 14(21):5289-93. PubMed ID: 15454213
[TBL] [Abstract][Full Text] [Related]
18. A new class of flavonol-based anti-prostate cancer agents: Design, synthesis, and evaluation in cell models.
Li X; Chen G; Zhang X; Zhang Q; Zheng S; Wang G; Chen QH
Bioorg Med Chem Lett; 2016 Sep; 26(17):4241-5. PubMed ID: 27476422
[TBL] [Abstract][Full Text] [Related]
19. Synthetic cannabinoid quinones: preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity.
Morales P; Vara D; Goméz-Cañas M; Zúñiga MC; Olea-Azar C; Goya P; Fernández-Ruiz J; Díaz-Laviada I; Jagerovic N
Eur J Med Chem; 2013; 70():111-9. PubMed ID: 24141201
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of novel arylpiperazine derivatives on human prostate cancer cell lines.
Chen H; Xu F; Liang X; Xu BB; Yang ZL; He XL; Huang BY; Yuan M
Bioorg Med Chem Lett; 2015 Jan; 25(2):285-7. PubMed ID: 25488843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
